Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RVV-Valpha

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Chronic hepatitis C, which is caused by infection with the hepatitis C virus (HCV), is a global health problem. Using a mouse… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
Comparison of TCRαβ repertoires of myelin oligodendrocyte glycoprotein (MOG)-specific T lymphocytes in C57BL/6 and TdT-deficient… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
2005
2005
PURPOSE We determined if vaccinia virus (VV) mediated delivery of human tumor suppressor p53 is safe and effective for bladder… Expand
2005
2005
T cell repertoires observed in response to immunodominant and subdominant peptides include private, i.e., specific for each… Expand
2004
2004
A potent toxin with phospholipase A2 (PLA2) and hemolytic activity in vitro was purified from the Russell's viper venom of… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2001
2001
Recombinant viruses can produce cytokines in tumors mobilizing an immune response to tumor cells. In this study, the authors… Expand
2001
2001
We describe the X-ray crystallographic structure of a murine T cell receptor (TCR) Valpha domain ("Valpha85.33"; AV11S5-AJ17) to… Expand
2000
2000
Our previous studies have shown that vaccinia virus (VV) expressing p53, interleukin-2 (IL-2), and interleukin-12 (IL-12) results… Expand
1996
1996
The efficacy of a recombinant vaccinia virus (rvv-mGM-CSF) expressing murine granulocyte-macrophage colony stimulating factor (GM… Expand
1996
1996
Two related glycoproteins (G and G(NS)) encoded in the bovine ephemeral fever virus (BEFV) genome were expressed from recombinant… Expand
  • figure 1
  • figure 3
  • table 1
  • figure 4
  • figure 5